Carestream Molecular Imaging Expands KODAK X-SIGHT Nanosphere Conjugates Product Line

JUNE 2, 2008

NEW HAVEN, Conn., June 2 — Carestream Molecular Imaging, a division of Carestream Health, Inc., today announced KODAK X-SIGHT Nanosphere Conjugates labeled with Streptavidin, expanding the KODAK X-SIGHT Imaging Agent family of products. This new product provides an effective means for life science researchers to detect biotinylated probes in fluorescent molecular biology research applications. These Streptavidin conjugates are fully biocompatible and ideal for both in vivo and in vitro applications, providing outstanding photostability and brightness.

The new KODAK X-SIGHT Nanosphere Conjugates labeled with Streptavidin will be offered in four distinct wavelengths from ultraviolet (UV) to near infrared (near IR). They provide an incredibly bright and robust platform for translating molecular imaging experiments from in vitro to in vivo applications.

“Our novel family of X-SIGHT Nanospheres is gaining traction among life science researchers due to its organic composition and superior performance,” said Stephanie Chiang, Worldwide Director, Imaging Agent Business, Carestream Molecular Imaging. “Streptavidin is a popular protein used by many life science and medical researchers as a secondary detection reagent, and we expect this new conjugate to provide a safe and effective means for detecting biotinylated probes in fluorescent molecular imaging applications.”

The KODAK X-SIGHT imaging agent family also includes KODAK X-SIGHT Nanospheres and KODAK X-SIGHT Large Stokes Shift Dyes, which are also offered in a variety of conjugated forms. While the KODAK X-SIGHT Imaging Agents have been optimized for KODAK In-Vivo Imaging Systems and KODAK Image Stations, they are compatible with other commercially available digital imaging systems. The KODAK X-SIGHT Imaging Agent product line further expands the breadth of leading edge solutions offered by Carestream Molecular Imaging to help accelerate life science and drug discovery research.

Availability

KODAK X-SIGHT Nanosphere Conjugates labeled with Streptavidin will be available in July. For more information on KODAK X-SIGHT Imaging Agents, please go to www.MIstore.carestreamhealth.com.

###

About Carestream Molecular Imaging

Carestream Molecular Imaging, a division of Carestream Health, Inc., develops and markets high performance digital imaging systems, imaging agents, film and accessories under the KODAK brand for the life science research, specimen radiography and drug discovery/development market segments. For more information, visit http://www.carestreamhealth.com/en/US/en/health/s2/

or call 1-877-747-4357, express code 7. Outside of the United States, call 1-203-786-5657.

About Carestream Health, Inc.

Carestream Health, Inc. is a leading provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging solutions for the life science research and drug discovery/development market segments; and x-ray film and digital x-ray products for the non-destructive testing market. The company emerged in 2007 when Onex Corporation (TSX: OCX) of Toronto, Canada, purchased Eastman Kodak Company’s Health Group. For more information about Carestream Health, contact your Carestream Health representative or visit www.carestreamhealth.com.

CARESTREAM and X-SIGHT are trademarks of Carestream Health, Inc.

KODAK is a trademark of Kodak used under license.

2008